John McCabe
Director of Finance/CFO at DEM BioPharma, Inc.
Profile
John McCabe Operating Partner at Longwood Fund and COO/CFO of Longwood-founded DEM Bio.
John most recently served as Chief Financial Officer of Oncorus.
Prior to joining Oncorus, John served as CFO of Flex Pharma, Inc., which is now known as Salarius Pharmaceuticals, Inc. Before joining Flex Pharma in 2014, John served as Vice President and Chief Accounting Officer with ARIAD Pharmaceuticals, Inc. from 2013 to 2014, which was acquired by Takeda Pharmaceuticals, Ltd., and is now part of Takeda Oncology Company.
Previously, John served as Vice President and Corporate Controller at Charles River Associates from 2009 to 2013, where he was responsible for all aspects of global financial accounting, planning and reporting.
John also previously served as Director and Strategic Business Unit Controller at Biogen, managing all accounting and government pricing functions for the U.S.
commercial business.
John began his career at Arthur Andersen & Co., and he later held financial positions at Performance Technologies, Inc. and IP.com.
John holds B.S.
degrees in accounting and management information systems from Babson College, and an M.B.A from the University of Massachusetts at Amherst.
John McCabe active positions
| Companies | Position | Start |
|---|---|---|
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 2022-03-31 |
DEM BioPharma, Inc.
 DEM BioPharma, Inc. Pharmaceuticals: MajorHealth Technology DEM BioPharma, Inc. is an American company that pioneers the next generation of immunotherapeutics to eliminate tumors by targeting 'don't eat me' and 'eat me' signals on cancer cells, macrophages, and other myeloid effector cells. The company is based in Cambridge, MA. The proprietary CHOMP™ platform utilizes CRISPR-based functional genomic screens to discover and validate new signals that could enhance cancer cell elimination through increased phagocytosis. The company was founded by Longwood Fund and builds on groundbreaking functional genomics research and discoveries in macrophage biology from its scientific co-founders. Nenad Grmusa has been the CEO of the company since 2022. | Director of Finance/CFO | 2022-03-31 |
Former positions of John McCabe
| Companies | Position | End |
|---|---|---|
| ONCORUS, INC. | Director of Finance/CFO | 2022-03-31 |
Flex Pharma, Inc.
 Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | Director of Finance/CFO | 2019-06-30 |
| ARIAD PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2014-04-30 |
Charles River Associates (Asia Pacific) Ltd.
 Charles River Associates (Asia Pacific) Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Associates (Asia Pacific) Ltd. provides economic, financial, and management consulting services. It is a subsidiary of CRA International, Inc. The company is headquartered in Brisbane, Australia. | Comptroller/Controller/Auditor | 2013-04-30 |
| BIOGEN INC. | Corporate Officer/Principal | 2009-05-31 |
Training of John McCabe
| Babson College | Undergraduate Degree |
| University of Massachusetts | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| ONCORUS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
Charles River Associates (Asia Pacific) Ltd.
Charles River Associates (Asia Pacific) Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Associates (Asia Pacific) Ltd. provides economic, financial, and management consulting services. It is a subsidiary of CRA International, Inc. The company is headquartered in Brisbane, Australia. | Commercial Services |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Finance |
DEM BioPharma, Inc.
DEM BioPharma, Inc. Pharmaceuticals: MajorHealth Technology DEM BioPharma, Inc. is an American company that pioneers the next generation of immunotherapeutics to eliminate tumors by targeting 'don't eat me' and 'eat me' signals on cancer cells, macrophages, and other myeloid effector cells. The company is based in Cambridge, MA. The proprietary CHOMP™ platform utilizes CRISPR-based functional genomic screens to discover and validate new signals that could enhance cancer cell elimination through increased phagocytosis. The company was founded by Longwood Fund and builds on groundbreaking functional genomics research and discoveries in macrophage biology from its scientific co-founders. Nenad Grmusa has been the CEO of the company since 2022. | Health Technology |
- Stock Market
- Insiders
- John McCabe
